Latest News- Ibuprofen Active Pharmaceutical Ingredient (API) Market: Pharmaceutical is expected to lead the End-user segment during 2025-2029

The Ibuprofen Active Pharmaceutical Ingredient (API) Market is being driven by Increasing geriatric population

The Ibuprofen Active Pharmaceutical Ingredient (API) Market is expected to grow at a CAGR of 2.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 27389 thousand. In the pharmaceutical industry, the production of ibuprofen Active Pharmaceutical Ingredients (APIs) has seen a notable shift from in-house manufacturing to outsourcing to specialized drug manufacturing organizations. Initially, the global ibuprofen API market primarily focused on the production of early-stage intermediates. However, with advancements in technology and industry trends favoring cost savings and increased efficiency, many pharmaceutical companies have outsourced the production of advanced intermediates and final dosage forms for ibuprofen APIs, particularly for generic drugs. The decision to outsource is influenced by several factors, including the high cost of acquiring new in-house technologies and the need to optimize internal capacity. 

Get more information on Ibuprofen Active Pharmaceutical Ingredient (API) Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Pharmaceutical
  • Contract manufacturing organizations
• Product
  • Prescription
  • Over-the-counter
• Geography
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing geriatric population
• Evolving API manufacturing scenario in developing countries
• Increase in pharmaceutical and biopharmaceutical production

However, the market also witnesses some limitations, which are as follows:

• Stringent regulations on ibuprofen API
• Rising production cost of ibuprofen API
• Rise in number of counterfeit drugs

Benefits of Buying Global Ibuprofen Active Pharmaceutical Ingredient (API) Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Ibuprofen Active Pharmaceutical Ingredient (API) Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Ibuprofen Active Pharmaceutical Ingredient (API) market encompasses various aspects, including Ibuprofen Salt and Ester forms, Ibuprofen Formulations with diverse dosages and strengths, Ibuprofen Bioequivalence and Stability Testing, Ibuprofen Process Validation and Regulatory Affairs. Market dynamics, price trends, and packaging standards are also significant factors. The Patent Landscape, Manufacturing Capacity, Production Costs, and Sustainability Initiatives influence the industry. Quality Assurance, Analytical Methods, Clinical Trials, Patient Safety, Drug Interactions, Side Effects, and Therapeutic Applications are crucial considerations for Ibuprofen's use and development.

Market Research Overview

The Ibuprofen Active Pharmaceutical Ingredient (API) market is a significant segment within the larger global pharmaceuticals industry. This sector encompasses organizations involved in the research and development (R&D) or production of various pharmaceutical offerings, including generic drugs, non-generic drugs, and veterinary drugs. According to Technavio, the healthcare market, which includes the revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is projected to grow due to several factors. One key driver is the increasing global population aging, with Europe and the US anticipating substantial population growth among individuals over 60 years old by 2030 and 2050, respectively. This demographic shift will lead to an increased demand for pharmaceutical solutions, including Ibuprofen API, which is commonly used in drug formulation for various dosage forms, particularly oral solid dosages.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/